REGENXBIO Inc. (RGNX) Operating cash flow 2016–2025
REGENXBIO Inc. (RGNX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$124.0MFY2025 · since FY2016: -$48.6M → -$124.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$124.0M | +28.4% |
| FY2024 | -$173.1M | +20.7% |
| FY2023 | -$218.4M | -5.3% |
| FY2022 | -$207.5M | -194.8% |
| FY2021 | $218.9M | +504.9% |
| FY2020 | -$54.1M | +49.8% |
| FY2019 | -$107.7M | -202.9% |
| FY2018 | $104.6M | +280.5% |
| FY2017 | -$58.0M | -19.4% |
| FY2016 | -$48.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RGNX financial trends
RGNX RevenueRGNX Net incomeRGNX Net marginRGNX Gross profitRGNX Gross marginRGNX Operating incomeRGNX Operating marginRGNX Free cash flowRGNX Capital expendituresRGNX Return on equityRGNX Stock buybacksRGNX Dividends paidRGNX Total assetsRGNX Total liabilitiesRGNX Shareholders’ equityRGNX overview →